It was a historic week in the nation's capital as the Supreme Court heard oral arguments on four separate but intertwined issues regarding the constitutionality of the landmark Affordable Care Act (ACA). But that wasn't the only thing that happened in Washington this week: the House passed a budget bill that included substantial changes to the Medicare and Medicaid programs, and the FDA rejected a petition to ban the chemical bisphenol A, which is used in food packaging.
Read the full story: http://hcp.lv/HGddpd
Source: MedPage Today
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More